Skip to main content

Table 3 The 10 single predictors and the five best two- to four-predictor classification results predicting progression from MCI to AD dementia

From: Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia

Predictors

AUC

Youden index

Sensitivity

Specificity

PPV

NPV

Single predictors

 t-Tau

   

0.77

1.48

0.62

0.86

0.42

0.93

 HCV

   

0.74

1.45

0.63

0.82

0.42

0.92

 CDR-sb

   

0.73

1.38

0.45

0.93

0.35

0.95

 CERAD-DR

   

0.72

1.39

0.64

0.75

0.40

0.89

 MMSE

   

0.71

1.36

0.68

0.68

0.40

0.87

 p-Tau

   

0.69

1.41

0.81

0.61

0.50

0.86

 Aβ42

   

0.68

1.38

0.74

0.64

0.44

0.87

 Aβ42/Aβ40

   

0.66

1.34

0.59

0.75

0.37

0.88

 Aβ40

   

0.55

1.15

0.76

0.39

0.34

0.80

 APO E

   

0.50

1.05

0.41

0.64

0.26

0.47

Two-predictor combinations

 t-Tau

HCV

  

0.81

1.45

0.68

0.77

0.49

0.88

 t-Tau

CDR-sb

  

0.79

1.44

0.83

0.61

0.41

0.92

 t-Tau

MMSE

  

0.79

1.46

0.81

0.65

0.43

0.91

 t-Tau

CERAD-DR

  

0.78

1.43

0.62

0.81

0.52

0.87

 p-Tau

HCV

  

0.77

1.40

0.76

0.64

0.42

0.89

Three-predictor combinations

 t-Tau

HCV

CDR-sb

 

0.83

1.54

0.84

0.70

0.48

0.93

 t-Tau

HCV

MMSE

 

0.81

1.47

0.83

0.64

0.44

0.92

 t-Tau

MMSE

CDR-sb

 

0.81

1.47

0.76

0.70

0.46

0.90

 t-Tau

CDR-sb

CERAD-DR

 

0.80

1.48

0.79

0.70

0.47

0.91

 HCV

MMSE

Aβ42/Aβ40

 

0.80

1.48

0.78

0.70

0.45

0.91

Four-predictor combinations

 t-Tau

HCV

CDR-sb

Aβ42/Aβ40

0.82

1.55

0.89

0.67

0.47

0.95

 t-Tau

p-Tau

CDR-sb

Aβ42/Aβ40

0.82

1.49

0.78

0.71

0.47

0.91

 t-Tau

HCV

p-Tau

Aβ42/Aβ40

0.82

1.49

0.85

0.64

0.42

0.93

 t-Tau

HCV

CDR-sb

CERAD-DR

0.81

1.57

0.80

0.76

0.52

0.92

 HCV

MMSE

CDR-sb

Aβ42/Aβ40

0.81

1.51

0.86

0.65

0.46

0.93

  1. The predictors are sorted according to the AUC
  2. All values correspond to mean bootstrap-based cross-validated performance
  3. Aβ40 amyloid-beta1–40, Aβ42 amyloid-beta1–42, AD Alzheimer’s disease, AUC area under the curve, CDR-sb Clinical Dementia Rating–sum-of-boxes, CERAD-DR Consortium to Establish a Registry of Dementia–delayed recall, HCV hippocampal volume, MCI cognitive impairment, MMSE Mini-Mental State Examination, NPV negative predictive value, PPV positive predictive value, p-Tau phosphorylated tau, t-Tau total tau